PBYI vs MSFT: Which Stock is Better?
Side-by-side comparison of Puma Biotechnology Inc and Microsoft Corp in 2026
PBYI
Puma Biotechnology Inc
$7.47
MSFT
Microsoft Corp
$430.11
Key Metrics Comparison
| Metric | PBYI | MSFT | Winner |
|---|---|---|---|
| Market Cap | $368.35M | N/A | PBYI |
| P/E Ratio | 11.87 | 26.32 | PBYI |
| EPS (TTM) | $0.61 | $15.97 | MSFT |
| Revenue Growth | 0.3% | 0.2% | PBYI |
| Gross Margin | 74.5% | 68.6% | PBYI |
Analyze PBYI
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PBYI or MSFT a better investment?
Comparing PBYI and MSFT: Puma Biotechnology Inc has a market cap of $368.35M while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PBYI and MSFT?
PBYI (Puma Biotechnology Inc) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PBYI or MSFT?
Based on P/E ratios, PBYI trades at a lower multiple (11.9x vs 26.3x).
Which is growing faster: PBYI or MSFT?
PBYI has higher revenue growth at 0.3% vs 0.2% for MSFT.
Which company is more profitable: PBYI or MSFT?
Puma Biotechnology Inc (PBYI) has higher gross margins at 74.5% compared to 68.6% for MSFT.
Which is the larger company: PBYI or MSFT?
Puma Biotechnology Inc (PBYI) is larger with a market cap of $368.35M compared to N/A for MSFT.
Should I buy PBYI or MSFT in 2026?
Both PBYI and MSFT have investment merit. PBYI trades at $7.47 while MSFT trades at $430.11. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PBYI and MSFT stock?
Key differences: Market Cap ($368.35M vs N/A), P/E Ratio (11.9x vs 26.3x), Revenue Growth (0.3% vs 0.2%), Gross Margin (74.5% vs 68.6%).